This Is MS Multiple Sclerosis Knowledge & Support Community

RESULTS:
With regard to clinical disease activity, neuroimaging, and immune responses, the majority of patients in our cohort were stable. Decreased lymphocyte cell numbers and altered cell ratios returned to normal 14 months after cessation of natalizumab. No infectious complications were observed.

Link

--Frank

Frank wrote:RESULTS:
With regard to clinical disease activity, neuroimaging, and immune responses, the majority of patients in our cohort were stable. Decreased lymphocyte cell numbers and altered cell ratios returned to normal 14 months after cessation of natalizumab. No infectious complications were observed.

Link

--Frank

Frank...thanks for that info. BTW, is there any data for the other patients who didn't fall into the stable category? How long was your cohort on Tysabri and why did they stop using the drug? Thanks.

Harry

Hi Harry,

actually I have not been in any trial with Tysabri and I also dont know about any other publications on non stable patients.

I suspended my Tysabri infusions in favour of giving ABX a try for a year. After completing my ABX experience i deceided to go back to Tysabri, so far Tysabri seems to work fine for me.

--Frank

Frank wrote:Hi Harry,

actually I have not been in any trial with Tysabri and I also dont know about any other publications on non stable patients.

I suspended my Tysabri infusions in favour of giving ABX a try for a year. After completing my ABX experience i deceided to go back to Tysabri, so far Tysabri seems to work fine for me.

--Frank

Hi Frank,

Thanks for the update. That is one concern I have about Biogen....they don't tell us much if anything about the problem areas. Then again, their marketing people are very careful about this and don't want to shed any possible light on anything that could restrict sales.

Glad to hear that Tysabri seems to be working fine for you. Keep us posted along the way.

Harry